Project Grant HT94252310164
Award Date
7/1/23
Completion Date
6/30/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The University of Wisconsin-Madison will receive $1,377,598 under a three-year Project Grant from the Defense Health Agency to investigate medical solutions for targeting dysregulated histone-modifying enzymes driving prostate cancer cell survival after androgen deprivation therapy. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield...
This federal Project Grant award for $465,935.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research conducted by the University of Wisconsin - Madison to combine PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical...
The University of Wisconsin System has been awarded a $516,366 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will fund research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. This research initiative aims to transform healthcare for military service members and the broader...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
The University of Wisconsin System was awarded a $1,074,650 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2025 to August 31, 2029, will fund research to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by addressing...
The University of Wisconsin-Madison will receive $1,145,080 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from February 2021 to January 2024 to therapeutically target a lipid kinase regulator of mutant p53 in breast cancer. Through this award provided by the CFDA 12.420 program, the University of Wisconsin-Madison aims to investigate medical solutions for the battlefield and...
This federal Project Grant award of $1,251,230.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a breast cancer research project with the University of Wisconsin System. The award will fund a clinical trial focused on breakthrough breast cancer treatments, with a performance period from June 2025 to June 2029. The University of Wisconsin System, a leading public research institution, will serve as the primary awardee and perform the...
The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from April 15, 2025 to April 14, 2029, will support research to develop population modeling techniques aimed at optimizing equitable ovarian cancer outcomes. This work aligns with the program's focus on transforming healthcare for military service members, veterans, and the broader public through...
The University of Wisconsin System was awarded a $1,836,030 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a period of performance from September 1, 2025 to August 31, 2028, will fund research into the development of shark antibody radiopharmaceuticals for the treatment of prostate cancer. This specialized medical research initiative aims to transform healthcare for military service members, veterans, and...
The University of Wisconsin System was awarded a $777,500 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective June 1, 2025 through May 31, 2028, will support a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative...